Pachori A - Search Results

1

Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.

Harrison SA, Manghi FP, Smith WB, Alpenidze D, Aizenberg D, Klarenbeek N, Chen CY, Zuckerman E, Ravussin E, Charatcharoenwitthaya P, Cheng PN, Katchman H, Klein S, Ben-Ari Z, Mendonza AE, Zhang Y, Martic M, Ma S, Kao S, Tanner S, Pachori A, Badman MK, He Y, Ukomadu C, Sicard E. Harrison SA, et al. Among authors: pachori a. Nat Med. 2022 Jul;28(7):1432-1438. doi: 10.1038/s41591-022-01861-9. Epub 2022 Jun 20. Nat Med. 2022. PMID: 35725922 Free PMC article. Clinical Trial.

2

Glucosuric, renal and haemodynamic effects of licogliflozin, a dual inhibitor of sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2, in patients with chronic kidney disease: A randomized trial.

He Y, Pachori A, Chen P, Ma S, Mendonza AE, Amer A, Marbury TC, Hinder M. He Y, et al. Among authors: pachori a. Diabetes Obes Metab. 2021 May;23(5):1182-1190. doi: 10.1111/dom.14327. Epub 2021 Feb 16. Diabetes Obes Metab. 2021. PMID: 33512754 Clinical Trial.

3

[No title available]

[No authors listed] [No authors listed] PMID: 36164038

4

Basal insulin peglispro increases lipid oxidation, metabolic flexibility, thermogenesis and ketone bodies compared to insulin glargine in subjects with type 1 diabetes mellitus.

Porksen NK, Linnebjerg H, Lam ECQ, Garhyan P, Pachori A, Pratley RE, Smith SR. Porksen NK, et al. Among authors: pachori a. Diabetes Obes Metab. 2018 May;20(5):1193-1201. doi: 10.1111/dom.13215. Epub 2018 Feb 4. Diabetes Obes Metab. 2018. PMID: 29316143 Clinical Trial.

5

Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin.

Katovich MJ, Pachori A. Katovich MJ, et al. Among authors: pachori a. Diabetes Obes Metab. 2000 Jan;2(1):3-14. doi: 10.1046/j.1463-1326.2000.00044.x. Diabetes Obes Metab. 2000. PMID: 11220351 Review. No abstract available.

6

Reduced skeletal muscle secreted frizzled-related protein 3 is associated with inflammation and insulin resistance.

Pachori AS, Madan M, Nunez Lopez YO, Yi F, Meyer C, Seyhan AA. Pachori AS, et al. Obesity (Silver Spring). 2017 Apr;25(4):697-703. doi: 10.1002/oby.21787. Epub 2017 Feb 27. Obesity (Silver Spring). 2017. PMID: 28240822

7

Metabolic adaptation characterizes short-term resistance to weight loss induced by a low-calorie diet in overweight/obese individuals.

Whytock KL, Corbin KD, Parsons SA, Pachori A, Bock CP, Jones KP, Smith JS, Yi F, Xie H, Petucci CJ, Gardell SJ, Smith SR. Whytock KL, et al. Among authors: pachori a. Am J Clin Nutr. 2021 Jul 1;114(1):267-280. doi: 10.1093/ajcn/nqab027. Am J Clin Nutr. 2021. PMID: 33826697 Free article.

8

Inability to induce hypertension in normotensive rat expressing AT(1) receptor antisense.

Pachori AS, Wang H, Gelband CH, Ferrario CM, Katovich MJ, Raizada MK. Pachori AS, et al. Circ Res. 2000 Jun 9;86(11):1167-72. doi: 10.1161/01.res.86.11.1167. Circ Res. 2000. PMID: 10850969

9

The future of hypertension therapy: sense, antisense, or nonsense?

Pachori AS, Huentelman MJ, Francis SC, Gelband CH, Katovich MJ, Raizada MK. Pachori AS, et al. Hypertension. 2001 Feb;37(2 Pt 2):357-64. doi: 10.1161/01.hyp.37.2.357. Hypertension. 2001. PMID: 11230300 Review.

10

Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension.

Katovich MJ, Reaves PY, Francis SC, Pachori AS, Wang HW, Raizada MK. Katovich MJ, et al. Among authors: pachori as. J Hypertens. 2001 Sep;19(9):1553-8. doi: 10.1097/00004872-200109000-00006. J Hypertens. 2001. PMID: 11564974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page